Medicure (CVE:MPH) Stock Crosses Below 200 Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.14 and traded as low as C$1.04. Medicure shares last traded at C$1.18, with a volume of 5,100 shares traded.

Medicure Stock Performance

The company has a 50 day moving average of C$1.13 and a 200 day moving average of C$1.14. The firm has a market cap of C$12.31 million, a price-to-earnings ratio of -1.82 and a beta of 0.49. The company has a quick ratio of 1.28, a current ratio of 1.04 and a debt-to-equity ratio of 6.34.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.